Dr. Lisa Larkin presents a session on the physiological changes of perimenopause and menopause, focusing on weight gain and body composition alterations. The discussion covers the pathophysiology of these transitions and examines the role of menopausal hormone therapy (MHT), including its benefits and risks for women with obesity.

Dr. Larkin explores the latest research on MHT's impact on metabolic parameters, insulin resistance, and lipid profiles, providing evidence-based insights for clinical practice.

Learning Objectives:

• Describe perimenopause and menopause pathophysiology and symptoms

• Analyze menopausal transition's impact on weight and body composition

• Assess menopausal hormone therapy (MHT) benefits and risks

This comprehensive session explores crucial intersections of women's health and cardiovascular disease. Cardiovascular experts Dr. Michael Honigberg and Dr. Amy Sarma join women's health specialist Dr. Lisa Larkin to present on cardiometabolic health, cardio-obstetrics, and the relationship between menopause and cardiovascular disease. The discussion includes cutting-edge research and clinical best practices.

A patient story grounds the scientific discourse in real-world impact. The session concludes with a debate and panel Q&A, allowing attendees to engage directly with these leading experts in the field.

This multifaceted approach provides a holistic view of women's cardiovascular health throughout different life stages.

Dr. Lisa Larkin explores the critical importance of menopause in women's health. This session examines how technological innovations in femtech are revolutionizing menopause care. Dr. Larkin discusses the latest advancements in symptom management, long-term health implications, and personalized treatment approaches. The presentation highlights the intersection of technology and healthcare in addressing this often overlooked phase of women's lives, emphasizing its significance for overall health and well-being.

Dr. Lisa Larkin presents a comprehensive look at breast cancer risk management. This session explores practical strategies for assessing individual risk factors and implementing effective reduction techniques. Dr. Larkin draws on the latest research and clinical experience to demonstrate that proactive breast cancer prevention is both achievable and crucial for women's health. Attendees will gain valuable insights into risk assessment tools, lifestyle modifications, and medical interventions that can significantly impact breast cancer risk.

Dr. Lisa Larkin addresses the critical role of healthcare providers (HCPs) in migraine management. This session explores current best practices for diagnosing and treating migraines, emphasizing the importance of a proactive approach. Dr. Larkin discusses cutting-edge treatments, preventive strategies, and patient education techniques that can significantly improve outcomes. The presentation aims to equip HCPs with practical tools and knowledge to effectively manage migraine cases, ultimately enhancing patient quality of life.

Panel discussion featuring pioneering Bearcat healthcare founders in a sector valued at over $12 trillion globally. These visionaries are driving change with disruptive technologies and innovative business models.

Ryan Fox, CEO of Orange Grove Bio, moderates a distinguished panel including:

• Dr. Marvin Slepian, Co-Founder of Teravus

• Dr. Jon Thompson, Founder of Standard Bariatrics

• Dr. Lisa Larkin, Founder of Ms. Medicine

The discussion explores how these leaders are reshaping healthcare and making a positive impact on society.